After 15 years I’ve learned not to place any concrete value on comments like these. We already knew that they were aiming at uplist as soon as possible (whenever that might be). And it’s been logical that whatever valuation has been placed on NGIO can’t include a covid vaccine since we don’t even have an IND. The 500 million value had to be coming from other assets.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links